"Boswellia" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A plant genus of the family BURSERACEAE used medicinally since ancient times. It is a source of salai guggal (the gum resin), boswellic acid (ursane type TRITERPENES), and FRANKINCENSE.
| Descriptor ID |
D029743
|
| MeSH Number(s) |
B01.650.940.800.575.912.250.162.111
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Boswellia".
Below are MeSH descriptors whose meaning is more specific than "Boswellia".
This graph shows the total number of publications written about "Boswellia" by people in this website by year, and whether "Boswellia" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2016 | 0 | 1 | 1 |
| 2017 | 1 | 1 | 2 |
| 2018 | 0 | 2 | 2 |
| 2019 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Boswellia" by people in Profiles.
-
Binding of boswellic acids to functional proteins of the SARS-CoV-2 virus: Bioinformatic studies. Arch Pharm (Weinheim). 2021 Nov; 354(11):e2100160.
-
Boswellic acids/Boswellia serrata extract as a potential COVID-19 therapeutic agent in the elderly. Inflammopharmacology. 2021 Aug; 29(4):1033-1048.
-
Boswellic acid has anti-inflammatory effects and enhances the anticancer activities of Temozolomide and Afatinib, an irreversible ErbB family blocker, in human glioblastoma cells. Phytother Res. 2019 06; 33(6):1670-1682.
-
Curcumin downregulates expression of opioid-related nociceptin receptor gene (OPRL1) in isolated neuroglia cells. Phytomedicine. 2018 Nov 15; 50:285-299.
-
Phytoproflex®: supplementary management of osteoarthrosis: a supplement registry. Minerva Med. 2018 Apr; 109(2):88-94.
-
A novel boswellic acids delivery form (Casperome®) in the management of musculoskeletal disorders: a review. Eur Rev Med Pharmacol Sci. 2017 Nov; 21(22):5258-5263.
-
Supplementation with a lecithin-based delivery form of Boswellia serrata extract (Casperome®) controls symptoms of mild irritable bowel syndrome. Eur Rev Med Pharmacol Sci. 2017 05; 21(9):2249-2254.
-
Movardol® (N-acetylglucosamine, Boswellia serrata, ginger) supplementation in the management of knee osteoarthritis: preliminary results from a 6-month registry study. Eur Rev Med Pharmacol Sci. 2016 12; 20(24):5198-5204.